Fmr LLC Revance Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 166,828 shares of RVNC stock, worth $428,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,828

Previous 7,628 2087.05%

Holding current value

$428,747

Previous $37,000 1056.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $4.73 $372,528 - $753,016	159,200 Added 2087.05%	166,828 $428,000
Q1 2024 May 13, 2024	BUY	$4.65 - $9.31 $26,951 - $53,960	5,796 Added 316.38%	7,628 $37,000
Q4 2023 Feb 13, 2024	SELL	$5.81 - $11.2 $11 Million - $21.2 Million	-1,892,275 Reduced 99.9%	1,832 $16,000
Q3 2023 Nov 13, 2023	SELL	$11.47 - $25.07 $708,937 - $1.55 Million	-61,808 Reduced 3.16%	1,894,107 $21.7 Million
Q2 2023 Aug 11, 2023	BUY	$24.7 - $37.61 $2.73 Million - $4.16 Million	110,683 Added 6.0%	1,955,915 $49.5 Million
Q1 2023 May 11, 2023	BUY	$18.36 - $35.27 $660,537 - $1.27 Million	35,977 Added 1.99%	1,845,232 $59.4 Million
Q4 2022 Feb 13, 2023	BUY	$18.32 - $30.66 $1.1 Million - $1.85 Million	60,265 Added 3.45%	1,809,255 $33.4 Million
Q3 2022 Nov 10, 2022	BUY	$14.33 - $28.47 $7.66 Million - $15.2 Million	534,672 Added 44.03%	1,748,990 $47.2 Million
Q2 2022 Aug 12, 2022	SELL	$11.52 - $20.4 $201,738 - $357,244	-17,512 Reduced 1.42%	1,214,318 $16.8 Million
Q1 2022 May 13, 2022	BUY	$12.36 - $20.31 $638,332 - $1.05 Million	51,645 Added 4.38%	1,231,830 $24 Million
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $18.8 Million - $42.1 Million	-1,510,971 Reduced 56.15%	1,180,185 $19.3 Million
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $106,832 - $137,622	-4,144 Reduced 0.15%	2,691,156 $75 Million
Q2 2021 Aug 13, 2021	BUY	$26.8 - $31.84 $72.2 Million - $85.8 Million	2,695,300 New	2,695,300 $79.9 Million

Others Institutions Holding RVNC

# of Institutions

200

Shares Held

81.3M

Call Options Held

490K

Put Options Held

143K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account